Gengraf and Vitamins drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Gengraf (cyclosporine) and Vitamins (ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e). Common drug interactions include diarrhoea among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Gengraf and Vitamins. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Gengraf?

Gengraf has active ingredients of cyclosporine. eHealthMe is studying from 960 Gengraf users. Check the latest studies of Gengraf.

What is Vitamins?

Vitamins has active ingredients of ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e. It is often used in vitamin supplementation. eHealthMe is studying from 122,457 Vitamins users. Check the latest studies of Vitamins.



On Aug, 06, 2026

23 people who take Gengraf and Vitamins together, and have interactions are studied.

Gengraf and Vitamins drug interactions.

What are the common drug interactions of Gengraf and Vitamins, by gender? *:

female:

  1. Diarrhoea
  2. Eustachian tube disorder (inflammation of the middle ear, commonly affects the eustachian tube)
  3. Eye infection
  4. Fungal infection
  5. Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
  6. Rash
  7. Tympanic membrane perforation (a break in continuity of ear drum)
  8. Viral infection
  9. Arthralgia (joint pain)
  10. Blood glucose decreased

male:

  1. Anaemia (lack of blood)
  2. Cancer pain
  3. Squamous cell carcinoma of skin (a cancer of a kind of epithelial cell, the squamous cell. these cells are the main part of the epidermis of the skin)
  4. Vision blurred
  5. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  6. Concomitant disease progression (progress in accompanying disease)
  7. Hepatic enzyme increased
  8. Hepatitis acute
  9. Palpitations (feelings or sensations that your heart is pounding or racing)
  10. Pneumonia

What are the common drug interactions of Gengraf and Vitamins, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Nephrolithiasis (calculi in the kidneys)

40-49:

n/a

50-59:

  1. Oedema peripheral (superficial swelling)
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Cancer pain
  4. Carcinoma in situ of eye
  5. Dysarthria (speech disorder)
  6. Epistaxis (bleed from the nose)
  7. Infection
  8. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
  9. Palpitations (feelings or sensations that your heart is pounding or racing)
  10. Pneumonia

60+:

  1. Asthenia (weakness)
  2. Confusional state
  3. Cancer pain
  4. Carcinoma in situ of eye
  5. Cardiac arrest
  6. Concomitant disease progression (progress in accompanying disease)
  7. Cough
  8. Death
  9. Dizziness
  10. Dysarthria (speech disorder)

What are the existing conditions these people have? *

  1. Pain: 4 people, 17.39%
  2. Diarrhea: 3 people, 13.04%
  3. Oedema Peripheral (superficial swelling): 2 people, 8.70%
  4. Joint Pain: 2 people, 8.70%
  5. Fever: 2 people, 8.70%
  6. Fabry's Disease (build up of a particular type of fat, called globotriaosylceramide, in the body's cells): 2 people, 8.70%
  7. Chronic Renal Failure (kidney failure): 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Gengraf and Vitamins?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Gengraf and Vitamins:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Gengraf:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Vitamins:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Gengraf and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vitamins and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on cyclosporine and ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e (the active ingredients of Gengraf and Vitamins, respectively), and Gengraf and Vitamins (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: